Aquestive Therapeutics Inc Earnings

The next earnings date for Aquestive Therapeutics Inc is August 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Aquestive Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
08/12/2025$-0.17

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Aquestive Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/05/2025Before Market$-0.22-179.38%
03/03/2025After Market$-0.16-21.28%
11/04/2024After Market$-0.130.00%
08/06/2024After Market$-0.0375.00%
05/07/2024After Market$-0.17-112.50%
03/05/2024After Market$-0.11-37.50%
11/06/2023After Market$-0.0372.73%
08/07/2023After Market$-0.1016.67%
05/02/2023After Market$-0.1236.84%
03/07/2023After Market$-0.230.00%
11/01/2022After Market$-0.2325.81%
08/02/2022After Market$-0.360.00%
05/03/2022After Market$-0.3221.95%
03/08/2022After Market$-0.3819.15%
11/02/2021After Market$-0.3717.78%
08/03/2021After Market$-0.3325.00%
05/04/2021After Market$-0.414.65%
03/09/2021After Market$-0.60-130.77%
11/04/2020After Market$-0.49-6.52%
08/04/2020After Market$-0.0783.72%
05/05/2020After Market$-0.49-4.26%
03/11/2020After Market$-0.48-23.08%
11/05/2019After Market$-0.5421.74%
08/06/2019After Market$-0.82-32.26%
05/08/2019Before Market$-0.59-18.00%
03/14/2019Before Market$-0.56-9.80%
11/06/2018After Market$-0.64-48.84%
09/04/2018Before Market$-1.90-691.67%
04/11/2018---$-0.47---
08/29/2007---$-0.25---

More About Aquestive Therapeutics Inc

Country
USA
Full Time Employees
142

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Aquestive Therapeutics Inc Earnings” Can Refer to the Aquestive Therapeutics Inc Earnings Date

Some people say “Aquestive Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Aquestive Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Aquestive Therapeutics Inc Stock on the Earnings Date

If you own Aquestive Therapeutics Inc stock (AQST) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Aquestive Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Aquestive Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Aquestive Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Aquestive Therapeutics Inc earnings or anything else related to the stock market.